Deep-Dive Due Diligence AI Generated Probe of Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares (IINN)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These auto-generated reports apply OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
35
$0.54
15
Speculative
Bearish
Earnings report
C
BIOTECH, MARKET DECLINE, FINANCIAL ANALYSIS
INSPIRA TECHNOLOGIES FACES CHALLENGES DESPITE EPS SURPRISE
IINN_OUT_1 [2025-04-14 09:48:56 -0400] 3922 Bytes | 982 tokens | Cum: 982 tkns (12.28% of 8k)
==========================================================================
Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Inspira Technologies Oxy (IINN) which is at 0.6160 up from 0.6160. So, I pulled together a bunch of data for you to look over real fast. It's still early, 9:48:55 AM on Mon Apr 14, 2025 -0400. So, what's the verdict? You're the expert!
--- COMPANY PROFILE ---
Company: Inspira Technologies Oxy (IINN)
IPO: 2021-07-14 (3 Years Ago)
Market Cap: $15,781,474
Shares Outstanding: 25,620,000
Exchange: XNAS
Description: Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Here’s the first list of news for Inspira Technologies Oxy:
C1 - Apr-07-25 08:30AM - Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
C2 - Mar-25-25 08:30AM - Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital
C3 - Mar-24-25 01:59PM - Market Alert: Inspira Technologies' Respiratory Tech Could Transform $19B Ventilator Market Amid Major Wave of Multi Billion Dollar Medtech Acquisitions
C4 - Mar-19-25 08:30AM - Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego
C5 - Mar-18-25 01:17PM - PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market
C6 - Mar-14-25 07:00AM - Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care
C7 - Mar-13-25 04:30PM - Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
C8 - Mar-11-25 08:30AM - Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
==============
-> THE ROLE FOR AI:
==============
1) You are the **AI analyst-investigator**. I am **ScanScor**, a unified document retrieval and report parser.
Your role is to examine all available company data and draw sound conclusions.
The company under analysis is: Inspira Technologies Oxy (IINN).
2) To request information, refer to any listed documents using their reference codes.
3) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
At the end, you'll be prompted to return these data pairs:
1) BRIEF_SUMMARY[] -- Write a brief summary
2) MARKET_SCORE[] -- Assign a Market Score
3) PRICE_TARGET[] -- Set a price target
4) AI_RPT_HEADLINE[] -- Generate a headline for the article
5) SQUEEZE_POTENTIAL[] -- Potential for this stock to become an active short squeeze play
6) TAGS[] -- 1 to 4 words for SEO tags
7) STOCK_TYPE[] -- Describe the type of investor style suited to this stock
8) PRIMARY_CATALYST[] -- What you believe caused this stock to move today
9) SENTIMENT[] -- Mkt sentiment of the opportunity
10) IMPROVEMENT_SUGGESTION[] -- What can we do better
11) ETHICAL_RATING[] -- Rate alignment with long-term shareholder interests
Restrict the next response to just 3 tokes until it's time for the summary and data pairs at the end.
Request a document with its reference code(s), such as:
- `C1`, `C2`, `C3`, etc.
- To load more documents, reply with: `NEX`
News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.
IINN_IN_2 [2025-04-14 09:48:56 -0400] 2 Bytes | 2 tokens | Cum: 984 tkns (12.30% of 8k)
==========================================================================
C3
IINN_OUT_3 [2025-04-14 09:49:03 -0400] 1098 Bytes | 289 tokens | Cum: 1273 tkns (15.91% of 8k)
==========================================================================
Showing C3 (chunk 1 of 6): C3:
**Market Alert: Inspira Technologies' Respiratory Tech Could Transform $19B Ventilator Market Amid Major Wave of Multi Billion Dollar Medtech Acquisitions**
Date: Mar-24-25 01:59PM
Source: (Business Wire)
URL: https://finance.yahoo.com/news/market-alert-inspira-technologies-respiratory-175900693.html
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
As FDA-cleared INSPIRA ART100 system begins deployment at top New York hospital amid $21B+ in recent medtech acquisitions including J&J's $13.1B Shockwave deal and Boston Scientific's $3.7B Axonics purchase, Company's innovative HYLA blood sensor achieves 96% accuracy in clinical trials as Inspira advances its flagship INSPIRA ART500 system targeting 20 million annual respiratory patients with AI technology
NEW YORK, March 24, 2025--(BUSINESS WIRE)--Market News Alerts Reports: Inspira Technologies (NASDAQ: IINN)*
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
IINN_IN_4 [2025-04-14 09:49:03 -0400] 681 Bytes | 136 tokens | Cum: 1409 tkns (17.61% of 8k)
==========================================================================
This market alert highlights the potential impact of Inspira Technologies' respiratory technology on the $19 billion ventilator market. The FDA-cleared INSPIRA ART100 system is beginning deployment at a top New York hospital. This comes at a time when the medtech sector is witnessing significant acquisitions, such as Johnson & Johnson's $13.1 billion purchase of Shockwave and Boston Scientific's $3.7 billion acquisition of Axonics. Additionally, Inspira Technologies' HYLA blood sensor has achieved 96% accuracy in clinical trials. The company is also advancing its INSPIRA ART500 system, which is aimed at 20 million annual respiratory patients and incorporates AI technology.
IINN_OUT_5 [2025-04-14 09:49:04 -0400] 488 Bytes | 119 tokens | Cum: 1528 tkns (19.10% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-03-13T20:38:12Z - Inspira Technologies faces Nasdaq delisting over share price By Investing.com...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
IINN_IN_6 [2025-04-14 09:49:04 -0400] 2 Bytes | 2 tokens | Cum: 1530 tkns (19.12% of 8k)
==========================================================================
A1
IINN_OUT_7 [2025-04-14 09:49:08 -0400] 1098 Bytes | 294 tokens | Cum: 1824 tkns (22.80% of 8k)
==========================================================================
Showing A1 (chunk 1 of 5): A1:
**Inspira Technologies faces Nasdaq delisting over share price By Investing.com**Date: 2025-03-13Source: {'uri': 'uk.investing.com', 'dataType': 'news', 'title': 'Investing.com UK'}URL: https://uk.investing.com/news/company-news/inspira-technologies-faces-nasdaq-delisting-over-share-price-93CH-3978958RA'ANANA, Israel - Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN), a developer of life-support and diagnostic technologies, disclosed today that it has received a notice from Nasdaq regarding non-compliance with the minimum bid price rule. The notification, dated March 10, 2025, indicates that the company's stock has closed below the required $1.00 per share threshold for 30 consecutive business days. According to InvestingPro data, the stock is currently trading at $0.70, having declined over 24% year-to-date and showing particularly weak momentum in recent weeks.
The Nasdaq Listin
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
IINN_IN_8 [2025-04-14 09:49:08 -0400] 3 Bytes | 2 tokens | Cum: 1826 tkns (22.82% of 8k)
==========================================================================
MOR
IINN_OUT_9 [2025-04-14 09:49:10 -0400] 1098 Bytes | 258 tokens | Cum: 2084 tkns (26.05% of 8k)
==========================================================================
Showing A1 (chunk 2 of 5): g Rule 5550(a)(2) sets the minimum bid price, and Inspira now has until September 8, 2025, to meet this requirement. The company must maintain a closing bid price of $1.00 or more for at least 10 consecutive business days within this 180-day period to regain compliance. With a market capitalization of just $17 million and an InvestingPro Financial Health Score rated as WEAK, the company faces significant challenges ahead.
If Inspira fails to comply by the deadline, it may be granted a second 180-day period to meet the criteria, provided it satisfies other initial listing standards for the Nasdaq Capital Market, except for the minimum bid price. During this time, the company may consider a reverse share split among other options to address the deficiency.
Inspira's ordinary shares will continue to be listed and traded on the Nasdaq Capital Market throughout the compliance period. The co
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
IINN_IN_10 [2025-04-14 09:49:10 -0400] 366 Bytes | 68 tokens | Cum: 2152 tkns (26.90% of 8k)
==========================================================================
It seems there might be a misunderstanding as I don't have direct access to the system or content you're referring to. I can help answer questions or provide information based on the details you provide. Could you clarify what specific information or analysis you need related to the text about Inspira and its compliance with Nasdaq's minimum bid price requirement?
IINN_OUT_11 [2025-04-14 09:49:11 -0400] 1037 Bytes | 298 tokens | Cum: 2450 tkns (30.63% of 8k)
==========================================================================
This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!
B1 - 2025-03-11T12:30:00Z - Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
B2 - 2025-03-04T13:30:00Z - Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy
B3 - 2025-02-05T13:30:00Z - Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor
B4 - 2025-01-27T13:30:00Z - Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support
B5 - 2025-01-22T13:30:00Z - Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital
B6 - 2025-01-07T13:15:00Z - Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai
Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
IINN_IN_12 [2025-04-14 09:49:11 -0400] 2 Bytes | 2 tokens | Cum: 2452 tkns (30.65% of 8k)
==========================================================================
B1
IINN_OUT_13 [2025-04-14 09:49:14 -0400] 728 Bytes | 192 tokens | Cum: 2644 tkns (33.05% of 8k)
==========================================================================
Showing B1 (chunk 1 of 1): B1:
**Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/pressreleases/25/03/n44244840/inspira-technologies-reports-full-year-2024-financial-results-and-provides-business-updatesInspira Technologies reported its full-year 2024 financial results, highlighting progress in its HYLA blood sensor and INSPIRA ART core technologies, as well as the deployment of its FDA-cleared INSPIRA ART100 system to leading hospitals.
--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)
IINN_IN_14 [2025-04-14 09:49:14 -0400] 406 Bytes | 75 tokens | Cum: 2719 tkns (33.99% of 8k)
==========================================================================
It appears that Inspira Technologies has published its financial results for the full year of 2024, emphasizing advancements in its HYLA blood sensor and INSPIRA ART core technologies. Additionally, the company has successfully deployed its FDA-cleared INSPIRA ART100 system to prominent hospitals. For further details or specific financial figures, additional sections or items might need to be requested.
IINN_OUT_15 [2025-04-14 09:49:15 -0400] 238 Bytes | 59 tokens | Cum: 2778 tkns (34.73% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
IINN_IN_16 [2025-04-14 09:49:15 -0400] 16 Bytes | 3 tokens | Cum: 2781 tkns (34.76% of 8k)
==========================================================================
Could you please
IINN_OUT_17 [2025-04-14 09:49:16 -0400] 251 Bytes | 78 tokens | Cum: 2859 tkns (35.74% of 8k)
==========================================================================
You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source
You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.
IINN_IN_18 [2025-04-14 09:49:16 -0400] 13 Bytes | 3 tokens | Cum: 2862 tkns (35.77% of 8k)
==========================================================================
It looks like
IINN_OUT_19 [2025-04-14 09:49:23 -0400] 4775 Bytes | 1152 tokens | Cum: 4014 tkns (50.18% of 8k)
==========================================================================
This is our set of metrics for {co_name}.
Please analyze the numbers.
+---------------------+-----------------------+------------------------+----------------------+
| Volume: 7,597 | Perf Month: -19.78% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+-----------------------+------------------------+----------------------+
| Avg Volume: 751.64K | Perf Quarter: -44.76% | Short Float: 0.31% | ROE: - |
+---------------------+-----------------------+------------------------+----------------------+
| Rel Volume: 0.18 | Index: - | Short Ratio: 0.10 | ROI: -235.17% |
+---------------------+-----------------------+------------------------+----------------------+
| RSI (14): 32.71 | Market Cap: 15.00M | Short Interest: 0.07M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+----------------------+
| ATR (14): 0.07 | Shs Outstand: 25.62M | Beta: 2.12 | EPS Surprise: 21.88% |
+---------------------+-----------------------+------------------------+----------------------+
| SMA20: -13.09% | Shs Float: 23.89M | Sales Q/Q: - | P/E: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA50: -24.69% | Inst Own: 4.54% | Sales past 5Y: 0.00% | Earnings: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA200: -46.29% | Insider Own: 6.75% | Employees: 48 | |
+---------------------+-----------------------+------------------------+----------------------+
| Perf Week: -2.06% | Insider Trans: 0.00% | Debt/Eq: 0.52 | |
+---------------------+-----------------------+------------------------+----------------------+
The next section covers any insider trading by {co_name} officers or majority shareholders (if available).
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 0.628
Average Volume: 283350.0
30-Day High: 0.775
30-Day Low: 0.59
No detailed financial data available.
==== END OF FINANCIAL REPORT ====
You are now requested to write a summary analysis of Inspira Technologies Oxy (IINN).
Please complete the report using the exact format:
FIELD[value]
1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Inspira Technologies Oxy.
2) MARKET_SCORE[]
This conversation was initiated because IINN is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for IINN.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.
3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, IINN could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect IINN to increase 50% from its current price of $0.62, say: PRICE_TARGET[0.92]
4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.
5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.
6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)
7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.
8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.
9) SENTIMENT[]
bullish, bearish, neutral, or mixed
10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Inspira Technologies Oxy.
11) ETHICAL_RATING[]
Rate Inspira Technologies Oxy’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.
Return only: FIELD[value] for each of the above 11 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.
Finally, thank you for participating!
IINN_IN_20 [2025-04-14 09:49:23 -0400] 819 Bytes | 177 tokens | Cum: 4191 tkns (52.39% of 8k)
==========================================================================
BRIEF_SUMMARY[Inspira Technologies Oxy (IINN) exhibits a significant downturn in performance over recent months with substantial declines across various time frames, accompanied by a low relative volume and negative ROI. Despite a positive EPS surprise, the company's market cap remains small and its sales growth stagnant, indicating potential challenges ahead.]
MARKET_SCORE[35]
PRICE_TARGET[0.54]
AI_RPT_HEADLINE[Inspira Technologies Faces Challenges Despite EPS Surprise]
SQUEEZE_POTENTIAL[15]
TAGS[biotech, market decline, financial analysis]
STOCK_TYPE[speculative]
PRIMARY_CATALYST[earnings report]
SENTIMENT[bearish]
IMPROVEMENT_SUGGESTION[Detailed current financial statements including total assets, liabilities, equity, revenue, and net income would greatly enhance the analysis.]
ETHICAL_RATING[C]
IINN_IN_21 [2025-04-14 09:49:23 -0400] 126 Bytes | 29 tokens | Cum: 4220 tkns (52.75% of 8k)
==========================================================================
====================================
[2025-04-14 09:49:23] # Analysis Completed
Elapsed Time: 28.02 seconds